U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Manufacturing Site Change Supplements: Content and Submission
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Manufacturing Site Change Supplements: Content and Submission Guidance for Industry and Food and Drug Administration Staff December 2018

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-2015-N-3454
Issued by:
Guidance Issuing Office
Center for Biologics Evaluation and Research
Center for Devices and Radiological Health

This guidance explains FDA’s current thinking regarding the following:
(A) What constitutes a manufacturing site change and when you should submit a PMA supplement for a site change;
(B) What documentation you should submit in a site change supplement; and
(C) The general factors FDA intends to consider when determining whether to conduct an establishment inspection prior to approval of a site change supplement.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2015-N-3454.

Back to Top